GSK Investigational Site

Waterloo, Ontario N2L 6H6

0 studies enrolling now · 11 studies all time

What they study most

Asthma, Deep Vein Thrombosis, Dermatitis, Atopic, Diabetes Mellitus, Type 2, Fibrillation, Atrial, Infections, Papillomavirus, Neoplasms, Prostate, Papillomavirus Vaccines, Psoriasis, Pulmonary Embolism, Venous Thromboembolism

Studies at this site

• A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma — Completed
• Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older — Completed
• Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study — Completed
• Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18 — Completed
• Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US — Completed
• A New Oral Treatment For Type II Diabetes Mellitus — Completed
• A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD) — Completed
• A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis — Completed
• ARI103094-Follow-Up Study for REDUCE Study Subjects — Completed
• Odiparcil For The Prevention Of Venous Thromboembolism — Completed
• Study In People With Type 2 Diabetes — Completed